Thalidomide, CAS 50-35-1 Free sample
Thalidomide, CAS 50-35-1, EE 99.9%, Thalidomide, CAS 50-35-1,HPLC more than 99.5%, Impurity less than 0.1%, Water less than 0.1%, stock keep 10-50kg.
Thalidomide, CAS 50-35-1 stable novel crystalline or amorphous form both we have, Thalidomide, CAS 50-35-1no any IP problem. Thalidomide, CAS 50-35-1 DMF filling, free sample of Thalidomide, CAS 50-35-1.
EOS Med Chem have already carried out Thalidomide, CAS 50-35-1 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Thalidomide, CAS 50-35-1 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Thalidomide, CAS 50-35-1 Intermeidates list, most from GMP plant:
Thalidomide, CAS 50-35-1 Intermediate 3343-28-0, stock 5.6kg, assay 98.5%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 117997-81-6, stock 6.9kg, assay 98.4%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 928776-59-4, stock 5.6kg, assay 98.6%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 600721-43-5, stock 9.2kg, assay 98.3%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 126663-38-5, stock 2.7kg, assay 98.8%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 22509-74-6, stock 4.9kg, assay 98.3%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 3343-29-1, stock 3.4kg, assay 99%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 56-86-0, stock 4kg, assay 98.5%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 6349-98-0, stock 5.1kg, assay 98.9%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 39739-04-3, stock 7.9kg, assay 98.1%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 861658-15-3, stock 7.6kg, assay 98.8%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 31140-42-8, stock 7kg, assay 98.9%, White powder.
Thalidomide, CAS 50-35-1 Intermediate 7607-72-9, stock 3.2kg, assay 98.5%, White powder.
Thalidomide, CAS 50-35-1 HNMR, MASS, COA, MSDS we have.
Thalidomide, CAS 50-35-1, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
